CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who ...

GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...

GLP-1 agonists like Ozempic are primarily used to treat type 2 diabetes. Its popularity has even influenced wholesale retailer Costco to sell Ozempic and Wegovy (another popular semaglutide) at its ...

Add Sam's Club to the list of retail pharmacy options for consumers who want to buy the pricey weight-loss drugs Ozempic and Wegovy. Sam's Club pharmacies now sell Novo Nordisk's Wegovy and Ozempic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Orlando restaurant is set to ...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...

Costco has struck a deal with drugmaker Novo Nordisk to sell the popular GLP-1 medications Ozempic and Wegovy for about half their usual price — $499 a month. The discount still requires a doctor’s ...

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and Wegovy maker restructures in the face of rising competition for its ...

Ozempic (semaglutide) is an injectable medication initially designed to manage type 2 diabetes. Over the past few years, its potential to aid weight loss has captured more public attention. When ...

Rhode Island is considering limiting access to popular weight-loss drugs for state workers and Medicaid enrollees to control rising costs. The cost of GLP-1 medications, such as Ozempic and Wegovy, ...